EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Nucleic Acid Therapeutics In Cancer A M Gewirtz

Name: Nucleic Acid Therapeutics In Cancer A M Gewirtz
SKU: BELL-4111588
Price: 31.00 USD
Availability: InStock
Rating: 4.1 (100 reviews)

SKU: BELL-4111588

$ 31.00 ~~$ 45.00~~ (-31%)

4.1

100 reviews

Nucleic Acid Therapeutics In Cancer A M Gewirtz instant download after payment.

Publisher: Humana Press

File Extension: PDF

File size: 10.92 MB

Pages: 233

Author: A M Gewirtz

ISBN: 9781588292582, 9781592597772, 1588292584, 1592597777

Language: English

Year: 2004

Product desciption

Nucleic Acid Therapeutics In Cancer A M Gewirtz by A M Gewirtz 9781588292582, 9781592597772, 1588292584, 1592597777 instant download after payment.

A cutting-edge review of the important issues underlying the therapeutic use of nucleic acid-mediated gene silencing. Topics range from basic methodology and delivery to targeting and clinical targets. The authors thoroughly explain the latest developments in RNA biology, as well as the underpinnings of RNA interference, oligodeoxynucleotide delivery into cells, and strategies for targeting these molecules to accessible regions within the mRNA. They also provide some examples of how these new therapeutic compounds are being used clinically.